Becton Dickinson Surges to 191st in Trading Volume Ranking with 4.64 Billion Shares Exchanged

On May 29, 2025, Becton's trading volume reached 4.64 billion, marking a significant 59.44% increase from the previous day, placing it at the 191st position in the day's stock market rankings. Becton Dickinson and Company (BDX) saw a modest rise of 0.47%.

PKO Investment Management Joint Stock Co has recently acquired a new stake in Becton Dickinson and Company (BDX). The investment firm purchased 1,000 shares of the company's stock, valued at approximately $100,000. This acquisition is part of PKO Investment Management's ongoing strategy to diversify its portfolio and capitalize on growth opportunities in the healthcare sector.

Becton Dickinson and Company (BDX) has announced the successful completion of its acquisition of C.R. Bard, Inc. The acquisition, valued at approximately $24 billion, is expected to strengthen Becton's position in the medical technology market. The deal will allow Becton to expand its product offerings and enhance its capabilities in the areas of vascular, urology, and oncology.

Becton Dickinson and Company (BDX) has reported strong financial results for the first quarter of 2025. The company's revenue increased by 5% year-over-year, driven by robust demand for its medical devices and diagnostic solutions. Becton's net income also saw a significant increase, reflecting the company's continued focus on operational efficiency and cost management.